The risk that Adar Poonawalla, CEO and owner of Serum Institute of India (SII), took on the coronavirus vaccine, by investing heavily in it much before it had completed its clinical trials, seems to be paying off well, as early trials are showing positive results. Pune-based SII is the world’s largest vaccine manufacturer by volume […]